BELLUS Health Inc
TSX:BLU

Watchlist Manager
BELLUS Health Inc Logo
BELLUS Health Inc
TSX:BLU
Watchlist
Price: 19.48 CAD -0.1% Market Closed
Market Cap: 2.5B CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

BLU Price Targets Summary
BELLUS Health Inc

There are no price targets for BLU.
BLU Lowest Forecast
Wall Street Target
Not Available
BLU Average Forecast
Wall Street Target
Not Available
BLU Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BELLUS Health Inc Competitors:
Price Targets
LEGN
Legend Biotech Corp
77% Upside
TH
Theratechnologies Inc
31% Upside
ZYME
Zymeworks Inc
59% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
14% Downside
LEGN
Legend Biotech Corp
77% Upside
TH
Theratechnologies Inc
31% Upside
ZYME
Zymeworks Inc
59% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
14% Downside
SYRE
Spyre Therapeutics Inc
236% Upside
AMGN
Amgen Inc
4% Upside
ELDN
Eledon Pharmaceuticals Inc
147% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Downside

Revenue
Forecast

Revenue Estimate
BELLUS Health Inc

For the last 8 years the compound annual growth rate for BELLUS Health Inc's revenue is -46%. The projected CAGR for the next 3 years is 439%.

-46%
Past Growth
439%
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
BELLUS Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
BELLUS Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
What are analyst estimates?

See Also

Summary
BLU intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLU stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLU stock valuation using valuation multiples.
Wall Street Estimates
BLU price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLU stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BLU's stock price target?
Not Available

BLU doesn't have any price targets made by Wall Street professionals.

What is BELLUS Health Inc's Revenue forecast?
Projected CAGR
439%

For the last 8 years the compound annual growth rate for BELLUS Health Inc's revenue is -46%. The projected CAGR for the next 3 years is 439%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 269,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.